08/13/2024 3:42 PM | Acumen Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024 6:48 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 4:26 PM | Acumen Pharmaceuticals (Issuer) Kolchinsky Peter (Reporting) RA Capital Healthcare Fund LP (Reporting) RA CAPITAL MANAGEMENT, L.P. (Reporting) RA Capital Nexus Fund II, L.P. (Reporting) Shah Rajeev M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:40 PM | Acumen Pharmaceuticals (Issuer) Drapkin Kimberlee C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:41 PM | Acumen Pharmaceuticals (Issuer) Fountain Nathan B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:46 PM | Acumen Pharmaceuticals (Issuer) Porter Derrell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:49 PM | Acumen Pharmaceuticals (Issuer) Stalfort John A III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/10/2024 3:51 PM | Acumen Pharmaceuticals (Issuer) Stoppel Laura (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 3:36 PM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:47 PM | Acumen Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024 6:35 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 11:15 PM | Acumen Pharmaceuticals (Filer)
| Form EFFECT | |
04/22/2024 3:33 PM | Acumen Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024 3:30 PM | Acumen Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2024 3:31 PM | Acumen Pharmaceuticals (Filer)
| Form DEFA14A | |
03/27/2024 3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/27/2024 3:34 PM | Acumen Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/26/2024 8:16 AM | Acumen Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/26/2024 6:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:05 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:32 AM | Acumen Pharmaceuticals (Subject) Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/06/2024 8:02 AM | Acumen Pharmaceuticals (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G | |
02/01/2024 4:01 PM | Acumen Pharmaceuticals (Issuer) Doherty James J. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/01/2024 4:02 PM | Acumen Pharmaceuticals (Issuer) Doherty James J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 6:16 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 3:22 PM | Acumen Pharmaceuticals (Subject) MURRAY JAMES B JR (Filed by)
| Form SC 13G/A | |
01/19/2024 6:04 PM | Acumen Pharmaceuticals (Issuer) Barton Russell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:05 PM | Acumen Pharmaceuticals (Issuer) Siemers Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:05 PM | Acumen Pharmaceuticals (Issuer) Zuga Matt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:06 PM | Acumen Pharmaceuticals (Issuer) Meisner Derek M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 6:07 PM | Acumen Pharmaceuticals (Issuer) OConnell Daniel Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:35 PM | Acumen Pharmaceuticals (Subject) OConnell Daniel Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024 3:36 PM | Acumen Pharmaceuticals (Subject) Meisner Derek M (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:27 PM | Acumen Pharmaceuticals (Subject) Zuga Matt (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:28 PM | Acumen Pharmaceuticals (Subject) Barton Russell (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024 3:29 PM | Acumen Pharmaceuticals (Subject) Siemers Eric (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024 7:42 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2024 7:33 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:20 PM | Acumen Pharmaceuticals (Issuer) Zuga Matt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:21 PM | Acumen Pharmaceuticals (Issuer) Siemers Eric (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:22 PM | Acumen Pharmaceuticals (Issuer) Meisner Derek M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Biden’s Capital Gains Tax to Devastate Savings! (Ad) Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << |
01/04/2024 3:23 PM | Acumen Pharmaceuticals (Issuer) Barton Russell (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:18 PM | Acumen Pharmaceuticals (Issuer) OConnell Daniel Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 6:45 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 6:20 AM | Acumen Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |